Bone Remodelling Markers in Rheumatoid Arthritis

Fardellone, Patrice; Séjourné, Alice; Paccou, Julien; Goëb, Vincent

Type de document :

Compte-rendu et recension critique d'ouvrage

DOI :

10.1155/2014/484280

Titre :

Bone Remodelling Markers in Rheumatoid Arthritis

Auteur(s) :

Fardellone, Patrice [Auteur]
CHU Amiens-Picardie
Mécanismes physiopathologiques et conséquences des calcifications cardiovasculaires - UR UPJV 7517 [MP3CV]
Séjourné, Alice [Auteur]
CHU Amiens-Picardie
Paccou, Julien [Auteur]

Marrow Adiposity & Bone Lab - Adiposité Médullaire et Os - ULR 4490 [MABLab]
Université de Lille
CHU Amiens-Picardie
Mécanismes physiopathologiques et conséquences des calcifications cardiovasculaires - UR UPJV 7517 [MP3CV]
Goëb, Vincent [Auteur]
Service de Rhumatologie [CHU Rouen]

Titre de la revue :

Mediators of Inflammation

Pagination :

1-5

Éditeur :

Hindawi Publishing Corporation

Date de publication :

2014

ISSN :

0962-9351

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

Bone loss in rheumatoid arthritis (RA) patients results from chronic inflammation and can lead to osteoporosis and fractures. A few bone remodeling markers have been studied in RA witnessing bone formation (osteocalcin), ...
Lire la suite >Bone loss in rheumatoid arthritis (RA) patients results from chronic inflammation and can lead to osteoporosis and fractures. A few bone remodeling markers have been studied in RA witnessing bone formation (osteocalcin), serum aminoterminal propeptide of type I collagen (PINP), serum carboxyterminal propeptide of type I collagen (ICTP), bone alkaline phosphatase (BAP), osteocalcin (OC), and bone resorption: C-terminal telopeptide of type 1 collagen (I-CTX), N-terminal telopeptide of type 1 collagen (I-NTX), pyridinolines (DPD and PYD), and tartrate-resistant acid phosphatase (TRAP). Bone resorption can be seen either in periarticular bone (demineralization and erosion) or in the total skeleton (osteoporosis). Whatever the location, bone resorption results from activation of osteoclasts when the ratio between osteoprotegerin and receptor activator of nuclear factor kappa-B ligand (OPG/RANKL) is decreased under influence of various proinflammatory cytokines. Bone remodeling markers also allow physicians to evaluate the effect of drugs used in RA like biologic agents, which reduce inflammation and exert a protecting effect on bone. We will discuss in this review changes in bone markers remodeling in patients with RA treated with biologics.Lire moins >

Langue :

Anglais

Vulgarisation :

Non

Collections :

Marrow Adiposity & Bone Lab (MABLab) - ULR 4490

Source :

Harvested from HAL

Fichiers

484280.pdf
Accès libre
Accéder au document

document
Accès libre
Accéder au document

484280.pdf
Accès libre
Accéder au document

Bone Remodelling Markers in Rheumatoid Arthritis BibTeX CSV Excel RIS

Fichiers

Bone Remodelling Markers in Rheumatoid Arthritis

BibTeX

CSV

Excel

RIS